Hillman Capital Management
Hillman Capital Management reported 54 stocks worth $138M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are CVS (4.2%), BIIB (3.8%) and DD (3.7%). Compared with Q1 2026, the fund opened new positions in DD, VEEV and ACN, added to ADBE, EFA and NKE, trimmed CVS, BIIB and BAX and sold out of DD, GE and SPYM.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() CVS Cvs Health Corp | $5.7M | 4.2% | 55K | −12K (−18%) | 8 of 8 | |
| 2 | ![]() BIIB Biogen Inc | $5.2M | 3.8% | 24K | −5,547 (−19%) | 8 of 8 | |
| 3 | ![]() DD Dupont DE Nemours Inc Common Stock | $5.1M | 3.7% | 38K | New position | 1 of 8 | |
| 4 | WARNER BROS DISCOVERY IN | $5.1M | 3.7% | 190K | −6,323 (−3%) | 8 of 8 | |
| 5 | ![]() BAX Baxter Intl Inc | $5M | 3.6% | 236K | −11K (−5%) | 8 of 8 | |
| 6 | ![]() IFF INTERNATIONAL FLAVORS&FRAGRA | $5M | 3.6% | 63K | −9,898 (−14%) | 8 of 8 | |
| 7 | ![]() GSK Gsk PLC ADR F | $4.8M | 3.5% | 92K | −5,049 (−5%) | 8 of 8 | |
| 8 | ![]() KMX Carmax Inc | $4.8M | 3.5% | 91K | −18K (−16%) | 8 of 8 | |
| 9 | ![]() BA Boeing Co | $4.7M | 3.4% | 22K | −752 (−3%) | 8 of 8 | |
| 10 | ![]() ZBH Zimmer Biomet Hldgs Inc | $4.6M | 3.4% | 54K | −1,757 (−3%) | 8 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Hillman Capital Management 13F FAQ
What does Hillman Capital Management own?
Hillman Capital Management reported 54 stocks worth $138M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are CVS (4.2%), BIIB (3.8%) and DD (3.7%). The table above lists every position in the filing (the top 10 without an account).
What did Hillman Capital Management buy and sell in Q2 2026?
Compared with Q1 2026: 3 new positions, 14 added to, 34 trimmed and 5 sold out. New positions include DD, VEEV and ACN. It sold all of DD, GE and SPYM.
When will Hillman Capital Management file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Hillman Capital Management's portfolio worth?
The Q2 2026 filing reports $138M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.












